XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 10,831 $ 12,329
General and administrative 15,138 16,088
Total operating expenses 25,969 28,417
Loss from operations (25,969) (28,417)
Other income (expense):    
Interest income, net 2,406 280
Other (expense) income, net (44) 417
Net loss before income taxes (23,607) (27,720)
Income taxes 438 6
Net loss (24,045) (27,726)
Other comprehensive income (loss):    
Foreign currency translation income (loss), net of tax 104 (393)
Unrealized gain (loss) on marketable securities, net of tax 445 (823)
Comprehensive loss $ (23,496) $ (28,942)
Net loss per share attributable to ordinary shareholders, basic (in dollars per share) $ (0.22) $ (0.26)
Net loss per share attributable to ordinary shareholders, diluted (in dollars per share) $ (0.22) $ (0.26)
Weighted-average shares outstanding used in computing net loss per share attributable to ordinary shareholders, basic (in shares) 107,162,025 107,275,458
Weighted-average shares outstanding used in computing net loss per share attributable to ordinary shareholders, diluted (in shares) 107,162,025 107,275,458